PT Pyridam Farma Tbk (PYFA.JK)
IDR 208.0
(-3.7%)
IDR 208.0
(-3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -103.98 Billion | 275.24 Billion | 39.58 Billion | 1.11 Billion | 17.6 Billion | 1.75 Billion |
| Net Income | -85.22 Billion | 275.24 Billion | 5.47 Billion | 22.1 Billion | 9.34 Billion | 8.44 Billion |
| Depreciation & Amortization | 57.44 Billion | 71.25 Billion | 31.54 Billion | 9.07 Billion | 7.42 Billion | 1.75 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -76.2 Billion | -71.25 Billion | 2.56 Billion | -30.06 Billion | 846.37 Million | -10.2 Billion |
| Investing Cash Flow | -22.46 Billion | -242.99 Billion | -371.55 Billion | -6.58 Billion | -1.7 Billion | -19.5 Billion |
| Investments in PPE | -23.66 Billion | -46.46 Billion | -222.03 Billion | -7.83 Billion | -3.27 Billion | -20.47 Billion |
| Acquisitions | 730.93 Million | -163.45 Billion | -108.5 Billion | 1.25 Billion | 1.56 Billion | 970.9 Million |
| Investment purchases | - | -37.22 Billion | -40.23 Billion | - | - | - |
| Sales/Maturities of investments | - | - | -2.47 Billion | - | - | - |
| Other Investing Activities | 466.71 Million | 4.14 Billion | 1.69 Billion | 1.11 Billion | 1.53 Billion | 970.9 Million |
| Financing Cash Flow | 79.83 Billion | 326.36 Billion | 370.07 Billion | 9.62 Billion | -12.56 Billion | 16.25 Billion |
| Debt repayment | -85.95 Billion | -268.72 Billion | -22.65 Billion | -9 Billion | -23.4 Billion | -18.41 Billion |
| Dividends payments | - | - | - | - | -2.14 Billion | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 165.78 Billion | 595.08 Billion | 392.72 Billion | 18.62 Billion | 12.97 Billion | 34.66 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 136.57 Billion | 47.73 Billion | 9.63 Billion | 5.29 Billion | 1.95 Billion | 379.64 Million |
| Cash at end of period | 89.96 Billion | 136.57 Billion | 47.73 Billion | 9.63 Billion | 5.29 Billion | 1.95 Billion |
| Capital Expenditure | -23.66 Billion | -46.46 Billion | -222.03 Billion | -7.83 Billion | -3.27 Billion | -20.47 Billion |
| Effect of forex changes on cash | -1.54 Million | -674.2 Thousand | -693.38 Thousand | 189.25 Million | 157.91 Million | 3.07 Billion |
| Net cash flow / Change in cash | -46.6 Billion | 88.84 Billion | 38.09 Billion | 4.34 Billion | 3.34 Billion | 1.57 Billion |
| Free Cash Flow | -127.64 Billion | 228.77 Billion | -182.44 Billion | -6.72 Billion | 14.33 Billion | -18.72 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -99.03 Billion | -69.87 Billion | -45.31 Billion | -85.22 Billion | -39.72 Billion | -8.81 Billion |
| Depreciation & Amortization | 11.86 Billion | 16.12 Billion | 13.21 Billion | 57.44 Billion | 15.48 Billion | 12.86 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -38.76 Billion | 250.49 Billion | 29.76 Billion | -76.2 Billion | -32.29 Billion | 53.51 Billion |
| Investing Cash Flow | -22.02 Billion | -2689.53 Billion | -2.78 Billion | -22.46 Billion | 5.28 Billion | -17.34 Billion |
| Investments in PPE | -19.5 Billion | -7.56 Billion | -2.89 Billion | -23.66 Billion | 4.97 Billion | -17.43 Billion |
| Acquisitions | - | -2681.94 Billion | 89.4 Million | 730.93 Million | 480.71 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 127 Million | -20.71 Million | 20.71 Million | 466.71 Million | -173.1 Million | 87.53 Million |
| Financing Cash Flow | 15.49 Billion | 2705.02 Billion | 395.22 Billion | 79.83 Billion | 19.45 Billion | 17.75 Billion |
| Debt repayment | -27.13 Billion | -1621.53 Billion | -396.79 Billion | -85.95 Billion | -21.39 Billion | -373.48 Billion |
| Dividends payments | - | -61.78 Billion | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1206.2 Billion | - | - | - | - |
| Other Financing Activities | -382.32 Billion | 1581.01 Billion | - | 165.78 Billion | 40.85 Billion | 391.24 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 649.76 Billion | 453.64 Billion | 89.96 Billion | 136.57 Billion | 121.76 Billion | 63.78 Billion |
| Cash at end of period | 505.42 Billion | 649.76 Billion | 453.64 Billion | 89.96 Billion | 89.96 Billion | 121.76 Billion |
| Capital Expenditure | -19.5 Billion | -7.56 Billion | -2.89 Billion | -23.66 Billion | 4.97 Billion | -17.43 Billion |
| Effect of forex changes on cash | - | - | -872.28 Thousand | -1.54 Million | -1.54 Million | -671.47 Thousand |
| Net cash flow / Change in cash | -144.33 Billion | 196.11 Billion | 363.67 Billion | -46.6 Billion | -31.79 Billion | 57.98 Billion |
| Free Cash Flow | -157.31 Billion | 173.05 Billion | -31.65 Billion | -127.64 Billion | -51.56 Billion | 40.14 Billion |
EHMEF
PMDKY
ALNT
M1GU
INNOVATIVE
CMW